Encrypted | Login

2019 AAPM Annual Meeting - Session: Rationale and Evidence for SBRT


This video is currently visible only to AAPM Members, Affiliates and Developing Country Educational Associates. Embargo periods are typically one year from the date the presentation was first published.


Introduction
Jimm Grimm, PhD Johns Hopkins University
JimmGrimmJr@yahoo.com


Handout(s): 146-47132-486612-149017.pdf
When you have finished the video, you may watch again, browse/search all videos, go back to the previous page, or watch another video in this session (see below).



All videos in this session:
Radiation Therapy Dose Response Modeling and Optimization of Fractionation Schedules with Cancer Stem Cells - Victoria Yu, MS UCLA School of Medicine
Role of Vascular Damage and Tumor Microenvironment in the Response of Tumors to SBRT and SRS - Chang Song, University of Minnesota Medical School
Biological Dose Escalation and Outcomes Modeling in the Era of Stereotactic Radiotherapy - David Carlson, PhD University of Pennsylvania
Immunomodulatory Effects of Stereotactic Body Radiation Therapy (SBRT): Preclinical Insights and Clinical Opportunities - Ariel Marciscano, Memorial Sloan Kettering Cancer Center
Q & A -
Graph includes 161 member loads and 224 non-member loads (385 total loads). Exclude non-member? A load is defined as someone coming to this page, not necesarily that they pressed play, or watched the entire presentation.